Latest Breaking News On - Christophe hotermans - Page 1 : comparemela.com

AstraZeneca demonstrates commitment to patients living with amyloidosis at the 2024 International Symposium on Amyloidosis (ISA)

AstraZeneca: presents new clinical data at AAN -April 08, 2024 at 05:59 am EDT

Alexion and AstraZeneca will present new clinical and real-world data from its leading rare neurology portfolio at the American Academy of Neurology annual meeting in Denver from April 13-18, 2024..

Alexion Reveals C5 Inhibition Impact on NMOSD at MSMilan2023

AstraZeneca : Alexion data at 9th Joint ECTRIMS-ACTRIMS Meeting (MSMilan2023) showcase impact of C5 inhibition in NMOSD -October 11, 2023 at 02:21 am EDT

Alexion, AstraZeneca Rare Disease, will present new data at MSMilan2023, the 9th Joint Meeting of the European Committee for Treatment and Research in Multiple Sclerosis and Americas Committee.

AstraZeneca demonstrates pipeline and portfolio strength across malignant and rare haematological diseases